# Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

> **NCT00655044** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 3637 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir

## Key facts

- **NCT ID:** NCT00655044
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 3637 (ACTUAL)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655044, "Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00655044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*